KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Construction in Progress (2016 - 2025)

Gilead Sciences (GILD) has disclosed Construction in Progress for 16 consecutive years, with $745.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Construction in Progress rose 48.7% year-over-year to $745.0 million, compared with a TTM value of $745.0 million through Dec 2025, up 48.7%, and an annual FY2025 reading of $745.0 million, up 48.7% over the prior year.
  • Construction in Progress was $745.0 million for Q4 2025 at Gilead Sciences, up from $501.0 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $1.1 billion in Q4 2021 and bottomed at $501.0 million in Q4 2024.
  • Average Construction in Progress over 5 years is $736.6 million, with a median of $719.0 million recorded in 2022.
  • The sharpest move saw Construction in Progress crashed 31.98% in 2022, then surged 48.7% in 2025.
  • Year by year, Construction in Progress stood at $1.1 billion in 2021, then plummeted by 31.98% to $719.0 million in 2022, then fell by 8.07% to $661.0 million in 2023, then fell by 24.21% to $501.0 million in 2024, then soared by 48.7% to $745.0 million in 2025.
  • Business Quant data shows Construction in Progress for GILD at $745.0 million in Q4 2025, $501.0 million in Q4 2024, and $661.0 million in Q4 2023.